Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck …
J Guigay, A Aupérin, J Fayette, E Saada-Bouzid… - The Lancet …, 2021 - thelancet.com
Background Results from a phase 2 trial of the TPEx chemotherapy regimen (docetaxel–
platinum–cetuximab) showed promising results, with a median overall survival of 14· 0 …
platinum–cetuximab) showed promising results, with a median overall survival of 14· 0 …
[HTML][HTML] Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency
JS Heitmann, C Tandler, M Marconato, A Nelde… - Nature …, 2023 - nature.com
T-cell immunity is central for control of COVID-19, particularly in patients incapable of
mounting antibody responses. CoVac-1 is a peptide-based T-cell activator composed of …
mounting antibody responses. CoVac-1 is a peptide-based T-cell activator composed of …
[HTML][HTML] Investigation of spleen CXCR4 expression by [68Ga]Pentixafor PET in a cohort of 145 solid cancer patients
R Lewis, S Habringer, M Kircher, M Hefter, CA Peuker… - EJNMMI research, 2021 - Springer
Background The chemokine receptor CXCR4 is frequently overexpressed and associated
with adverse prognosis in most hematopoietic malignancies and solid cancers. Recently …
with adverse prognosis in most hematopoietic malignancies and solid cancers. Recently …
[HTML][HTML] High-affinity T-cell receptor specific for MyD88 L265P mutation for adoptive T-cell therapy of B-cell malignancies
Ö Çınar, B Brzezicha, C Grunert… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background Adoptive transfer of engineered T cells has shown remarkable success in B-cell
malignancies. However, the most common strategy of targeting lineage-specific antigens …
malignancies. However, the most common strategy of targeting lineage-specific antigens …
[HTML][HTML] Isolation of neoantigen-specific human T cell receptors from different human and murine repertoires
C Grunert, G Willimsky, CA Peuker, S Rhein… - Cancers, 2022 - mdpi.com
Simple Summary T cell-based immunotherapy has achieved remarkable clinical responses
in patients with cancer. Neoepitope-specific T cells can specifically recognize mutated tumor …
in patients with cancer. Neoepitope-specific T cells can specifically recognize mutated tumor …
MyD88 L265P Mutation-Specific TCR Gene Therapy for Treatment of B-Cell Lymphoma and Leukemia
Adoptive transfer of engineered T cells has shown remarkable success in hematopoietic
malignancies. However, the current most common strategy of targeting lineage-specific …
malignancies. However, the current most common strategy of targeting lineage-specific …
Future perspective: guidance for young physicians in the German Society of Hematology and Oncology: Network. Participate. Educate
C Oing, CA Peuker, J Müller, M Oldenburg, B Wörmann - Forum, 2018 - Springer
Kaum ein anderes medizinisches Fachgebiet erfährt eine solch rasante Entwicklung wie die
Hämatologie und Medizinische Onkologie. Angesichts der stetig wachsenden Zahl von …
Hämatologie und Medizinische Onkologie. Angesichts der stetig wachsenden Zahl von …
Treatment of metastatic uveal melanoma (mUM) directed by a comprehensive molecular tumour analysis program (CMTA).
S Leyvraz, T Kessler, M Schütte, M Lamping, S Burock… - 2018 - ascopubs.org
9566 Background: There is a lack of active treatment against mUM. Such “hard-to-treat”
tumour might benefit from treatment decisions driven by a complete genomic and …
tumour might benefit from treatment decisions driven by a complete genomic and …
Therapiemonitoring der neoadjuvanten Radio‑/Chemotherapie
Zusammenfassung Hintergrund Die neoadjuvante Therapie (NAT) dient insbesondere der
Verkleinerung von Tumoren mit Verbesserung der Resektabilität. Bildgebende Verfahren …
Verkleinerung von Tumoren mit Verbesserung der Resektabilität. Bildgebende Verfahren …
Mitgestalter gesucht
F Klein, CA Peuker - Im Fokus Onkologie, 2021 - Springer
Wer nicht nur DGHO-Mitglied wird, sondern auch dem AK Junge DGHO beitritt, eröffnet sich
viele Möglichkeiten zum Mitgestalten, sagt Peuker:„Jedes Mitglied ist eingeladen, an den AK …
viele Möglichkeiten zum Mitgestalten, sagt Peuker:„Jedes Mitglied ist eingeladen, an den AK …